Sernova Biotherapeutics Inc (TSX:SVA)
Canada · Delayed Price · Currency is CAD 0.1350
+0.0050 (3.85%)
Jul 6, 2026, 9:30 AM EST
Sernova Biotherapeutics Earnings Call Transcripts
Fiscal Year 2024
-
A regenerative medicine platform using a Cell Pouch system has shown promising results in Type 1 diabetes, with several patients achieving long-term insulin independence. Preclinical studies support the efficacy of iPSC-derived islet-like clusters, and new clinical trials are planned for 2026.